Drug Database
IN

influenza vaccine (Pandyflu)

✓ Approved

Panacea Biotec Limited · Vaccine · Vaccine

What is influenza vaccine?

influenza vaccine is a vaccine developed by Panacea Biotec Limited. It is approved for therapeutic indications via injectable (others) or intramuscular (im) injection.

Drug Profile

Brand NamesPandyflu
CompanyPanacea Biotec Limited
Drug ClassVaccine, Large Molecules
RouteInjectable (Others), Intramuscular (IM) Injection
StatusApproved

Related Research Articles

PubMedNPJ vaccines2026-09-05

Host cell entry and neutralisation sensitivity of H3N2 influenza A virus subclade K.

Moor Nicole N, Chen Nianzhen N, Behrens Georg M N GMN, Zhang Lu L et al.

In 2025, a mutated H3N2 lineage, subclade K, emerged, showing high activity in many regions. Mutations in the hemagglutinin (HA) may affect cell entry and antibody-mediated neutralisation. Using pseudovirus particles, we show that subclade K-HA drives augmented entry into certain cell lines and displays significant antibody evasion. Both phenotypes were linked to mutation A186D. Influenza vaccination significantly boosted H3N2 subclade K neutralisation, suggesting that current vaccines may provide considerable protection.

PubMedJournal of the College of Physicians and Surgeons--Pakistan : JCPSP2026-09-05

Pre-Pandemic Scientific Insights into Influenza A (H3N2): Viral Evolution, Host Responses, and Evidence-Based Preventive Strategies.

Ahmed Mostafa Ahmed Abdellah MAA, Khaliq Hafiz Muhammad Haseeb HMH

Null.

PubMedJournal of the College of Physicians and Surgeons--Pakistan : JCPSP2026-09-05

Decades of Dengue in Pakistan: Is It Finally Time for a Vaccine?

Rai Versha Rani VR

Null.

PubMedAllergy and asthma proceedings2026-09-05

Effective media communication in allergy and immunology: A practical framework for pediatric advocacy.

Berger William E WE

Background: Effective communication between physicians and the public has become increasingly important in the modern media environment. Pediatricians and allergist/immunologists play a critical role in shaping public understanding of conditions such as food allergy, asthma, and vaccine safety. Objective: The objective was to provide a practical framework for clinicians to engage effectively with media, improve public health messaging, and enhance patient outcomes through clear, accurate, and impactful communication. Methods: This was a narrative review of literature that integrates health communication, media engagement, pediatric advocacy, allergy and immunology, public health messaging, vaccine communication, and asthma and food allergy education. Results: Successful media engagement requires preparation, audience awareness, message clarity, and strategic delivery. Core principles include simplifying complex medical information; maintaining credibility; and focusing on key public health messages, such as early food introduction, asthma control, and vaccine safety. The RATIO framework (Research, Audience, Targeted Topic, Interview Redirecting, Optimism) provides a structured approach to media advocacy. Conclusion: Physician engagement with media is an essential extension of clinical care. Effective communication can improve public understanding, counter misinformation, promote evidence-based health behaviors, and substantially affect adherence and preventive behaviors, particularly in vaccination and chronic disease management, particularly in pediatric populations.

PubMedJournal of human hypertension2026-09-05

Childhood BMI trajectories and hypertension in adulthood: a population-based cohort study.

Searle Dominique D, Andersen Elisabeth Wreford EW, Aarestrup Julie J, Baker Jennifer L JL

Higher body mass index (BMI) in childhood is associated with hypertension (HTN) especially in young adulthood. We examined whether longitudinal patterns of BMI development in childhood are associated with HTN across adult ages. We included 124 670 children (51% boys), born between 1960-1996, from the Copenhagen School Health Records Register with height and weight measurements at ages 6-15 years. Latent class trajectory models were used to identify five sex-specific BMI trajectories: below-average, average, above-average, overweight, and obesity. Individuals were followed from age 25 in national health registers from 1995-2022 for HTN. Cox models were used to estimate sex-specific hazard ratios (HRs) with 95% confidence intervals (CIs) for HTN across childhood BMI trajectories, with adjustment for birth cohort and parental education. Follow-up was split into ages 25-39, 40-49, and 50-62 years. Over a median 18-year follow-up, 5 970 men (9.4%) and 5 712 women (9.3%) developed HTN. Men and women with above-average, overweight, and obesity childhood BMI trajectories had higher hazards of HTN than those with the average trajectory. Associations attenuated with age but remained significant. Compared to men with the average trajectory, the obesity trajectory was associated with a HR = 4.31 (95% CI: 3.45-5.37) at ages 25-39 and HR = 2.12 (1.63-2.76) at ages 50-62 years. Compared to women with the average trajectory, the obesity trajectory was associated with a HR = 3.53 (2.89-4.30) at ages 25-39 and HR = 2.19 (1.70-2.82) at ages 50-62 years. Childhood BMI trajectories are positively associated with adult HTN in a dose-response manner highlighting the potential value of early obesity prevention.

PubMedJournal of the College of Physicians and Surgeons--Pakistan : JCPSP2026-09-05

Postoperative Infection after Laparoscopic Cholecystectomy: Benchmarking Machine-Learning Models in a Real-World Cohort.

Zhao Hongwei H, Wang Jianzhe J, Chen Qi Q, Yang Hang H et al.

To benchmark machine-learning (ML) models for predicting postoperative infection after laparoscopic cholecystectomy (LC) in a real-world cohort. A descriptive study. Place and Duration of the Study: Department of General Surgery, Daqing People's Hospital, Daqing, China, from January 2016 to December 2025. Consecutive patients undergoing LC were included. Postoperative infection was defined as a clinically diagnosed or culture-proven infection during index hospitalisation or within 30 days after surgery, using CDC/NHSN-based criteria where applicable. The cohort (n = 1,155; 186 infections) was randomly split into training (n = 816) and internal validation sets (n = 339). Four classifiers [decision tree (DT), support vector machine with a radial basis function kernel (SVM-RBF), random forest (RF), and naive Bayes (NB)] were developed. Performance was assessed using AUC, accuracy, sensitivity, and specificity at a prespecified probability threshold of 0.50, with precision-recall analysis, calibration, decision curve analysis, and permutation feature importance serving as complementary assessments. On validation, NB and RF showed the best discrimination (AUCs = 0.824 and 0.809, respectively), while DT and SVM-RBF performed poorly (AUCs = 0.614 and 0.582, respectively). At the 0.50 threshold, SVM-RBF predicted all validation patients as non-infected, indicating complete classification failure for clinical use. RF achieved high specificity (0.974) and accuracy (0.903), whereas NB yielded higher sensitivity (0.417). The highest-ranked RF predictors were preoperative white blood cell group, age, perioperative acute cholecystitis, the preoperative length-of-stay group, obesity, and operation duration group. ML models showed heterogeneous performance for predicting postoperative infection after LC. NB and RF performed best on internal validation and may support early risk stratification when paired with model interpretability, clinical utility assessment, external validation, and threshold optimisation. SVM-RBF was unsuitable for this dataset at the fixed 0.50 threshold. Laparoscopic cholecystectomy, Postoperative infection, Real-world cohort, Machine learning, Risk stratification.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about influenza vaccine